Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 5,065,000 | 5,061,000 | 4,663,000 | 4,562,000 | 4,209,000 |
| Cost of Goods | 1,523,000 | 1,637,000 | 1,453,000 | 1,466,000 | 1,312,000 |
| Gross Profit | 3,542,000 | 3,424,000 | 3,210,000 | 3,095,000 | 2,897,000 |
| Operating Expenses | 2,495,000 | 2,605,000 | 2,288,000 | 2,417,000 | 2,164,000 |
| Operating Income | 1,048,000 | 819,000 | 921,000 | 675,000 | 733,000 |
| Interest Expense | 87,000 | 90,000 | 82,000 | 80,000 | 79,000 |
| Other Income | -22,000 | 212,000 | -34,000 | -10,000 | 15,000 |
| Pre-tax Income | 939,000 | 941,000 | 805,000 | 585,000 | 669,000 |
| Income Tax | 183,000 | 146,000 | 133,000 | 23,000 | 200,000 |
| Net Income Continuous | 756,000 | 795,000 | 672,000 | 562,000 | 469,000 |
| Minority Interests | N/A | -2,000 | -2,000 | -5,000 | N/A |
| Net Income | $755,000 | $797,000 | $674,000 | $567,000 | $469,000 |
| EPS Basic Total Ops | 0.51 | 0.54 | 0.46 | 0.38 | 0.32 |
| EPS Basic Continuous Ops | 0.51 | 0.54 | 0.45 | 0.38 | 0.32 |
| EPS Diluted Total Ops | 0.51 | 0.53 | 0.45 | 0.38 | 0.32 |
| EPS Diluted Continuous Ops | 0.51 | 0.53 | 0.45 | 0.38 | 0.32 |
| EPS Diluted Before Non-Recurring Items | 0.75 | 0.75 | 0.75 | 0.70 | 0.63 |
| EBITDA(a) | $1,389,000 | $1,201,000 | $1,247,000 | $1,137,000 | $1,039,000 |